{
    "protocolSection": {
        "identificationModule": {
            "nctId": "NCT06096441",
            "orgStudyIdInfo": {
                "id": "STUDY00001521"
            },
            "organization": {
                "fullName": "Nationwide Children's Hospital",
                "class": "OTHER"
            },
            "briefTitle": "FSHD Molecular Characterization",
            "officialTitle": "Clinical and Molecular Characterization of Facioscapulohumeral Muscular Dystrophy (FSHD)",
            "therapeuticArea": [
                "Other"
            ],
            "study": "fshd-molecular-characterization"
        },
        "statusModule": {
            "statusVerifiedDate": "2023-10",
            "overallStatus": "RECRUITING",
            "expandedAccessInfo": {
                "hasExpandedAccess": false
            },
            "startDateStruct": {
                "date": "2021-03-05",
                "type": "ACTUAL"
            },
            "primaryCompletionDateStruct": {
                "date": "2025-03-05",
                "type": "ESTIMATED"
            },
            "completionDateStruct": {
                "date": "2026-03-05",
                "type": "ESTIMATED"
            },
            "studyFirstSubmitDate": "2023-09-12",
            "studyFirstSubmitQcDate": "2023-10-20",
            "studyFirstPostDateStruct": {
                "date": "2023-10-23",
                "type": "ACTUAL"
            },
            "lastUpdateSubmitDate": "2023-10-20",
            "lastUpdatePostDateStruct": {
                "date": "2023-10-23",
                "type": "ACTUAL"
            }
        },
        "sponsorCollaboratorsModule": {
            "responsibleParty": {
                "type": "PRINCIPAL_INVESTIGATOR",
                "investigatorFullName": "Kevin Flanigan",
                "investigatorTitle": "Director, Center for Gene Therapy, Professor of Pediatrics and Neurology",
                "investigatorAffiliation": "Nationwide Children's Hospital"
            },
            "leadSponsor": {
                "name": "Nationwide Children's Hospital",
                "class": "OTHER"
            }
        },
        "oversightModule": {
            "oversightHasDmc": false,
            "isFdaRegulatedDrug": false,
            "isFdaRegulatedDevice": false
        },
        "descriptionModule": {
            "briefSummary": "To characterize the clinical and molecular phenotype of FSHD.",
            "detailedDescription": "The purpose of this study is to validate alterations in therapeutically relevant biomarkers in muscle tissue from FSHD patients. These biomarkers are responsive to the upregulation of the DUX4 gene and protein, which is the fundamental molecular defect in FSHD. In anticipation of a future clinical trial, the Investigators intend to assess the correlation between the expression of these relevant biomarkers and clinical functional measures. The Investigators will also explore the utility of muscle MRI in identifying regions of muscle suitable for sampling for relevant biomarkers, as MRI-related signal changes have been proposed as an anatomic marker of early FSHD pathology."
        },
        "conditionsModule": {
            "conditions": [
                "Facio-Scapulo-Humeral Dystrophy"
            ],
            "keywords": [
                "FSHD"
            ]
        },
        "designModule": {
            "studyType": "OBSERVATIONAL",
            "patientRegistry": false,
            "designInfo": {
                "observationalModel": "CASE_ONLY",
                "timePerspective": "PROSPECTIVE"
            },
            "bioSpec": {
                "retention": "SAMPLES_WITH_DNA",
                "description": "Collecting blood products (plasma and serum for RNA and DNA) and muscle biopsies."
            },
            "enrollmentInfo": {
                "count": 25,
                "type": "ESTIMATED"
            }
        },
        "outcomesModule": {
            "primaryOutcomes": [
                {
                    "measure": "Validation of Biomarkers",
                    "description": "To validate alterations in therapeutically relevant biomarkers in muscle tissue from FSHD participants. Each participant will provide data at a single timepoint. The data in totality will be reviewed upon study completion.",
                    "timeFrame": "Through study completed, anticipated to be 4 years."
                }
            ]
        },
        "eligibilityModule": {
            "eligibilityCriteria": "Inclusion Criteria:\n\n* 13 years or older\n* Genetically proven FSHD1 or FSHD2 as determined by the investigators\n\nExclusion Criteria:\n\n* Inability to complete an MRI scan (Adults only).\n* Other medical or cognitive issues that, in the opinion of the examiner, preclude accurate functional assessment.",
            "healthyVolunteers": false,
            "sex": "ALL",
            "minimumAge": "13 Years",
            "stdAges": [
                "CHILD",
                "ADULT",
                "OLDER_ADULT"
            ],
            "studyPopulation": "Subjects 13 years or older with facioscapulohumeral muscular dystrophy (FSHD).",
            "samplingMethod": "PROBABILITY_SAMPLE"
        },
        "contactsLocationsModule": {
            "centralContacts": [
                {
                    "name": "Sarah Atkins",
                    "role": "CONTACT",
                    "phone": "614-355-7686",
                    "email": "sarah.atkins@nationwidechildrens.org"
                }
            ],
            "overallOfficials": [
                {
                    "name": "Kevin Flanigan, MD",
                    "affiliation": "Nationwide Children's Hospital",
                    "role": "PRINCIPAL_INVESTIGATOR"
                }
            ],
            "locations": [
                {
                    "facility": "The Abigail Wexner Research Institute at Nationwide Children's Hospital",
                    "status": "RECRUITING",
                    "city": "Columbus",
                    "state": "Ohio",
                    "zip": "43205",
                    "country": "United States",
                    "contacts": [
                        {
                            "name": "Robyn Cunningham",
                            "role": "CONTACT",
                            "phone": "614-722-2599",
                            "email": "robyn.cunningham@nationwidechildrens.org"
                        }
                    ],
                    "geoPoint": {
                        "lat": 39.96118,
                        "lon": -82.99879
                    }
                }
            ]
        },
        "referencesModule": {
            "references": [
                {
                    "pmid": "31209064",
                    "type": "BACKGROUND",
                    "citation": "Amini Chermahini G, Rashnonejad A, Harper SQ. RNAscope in situ hybridization-based method for detecting DUX4 RNA expression in vitro. RNA. 2019 Sep;25(9):1211-1217. doi: 10.1261/rna.070177.118. Epub 2019 Jun 17."
                },
                {
                    "pmid": "22798623",
                    "type": "BACKGROUND",
                    "citation": "Jones TI, Chen JC, Rahimov F, Homma S, Arashiro P, Beermann ML, King OD, Miller JB, Kunkel LM, Emerson CP Jr, Wagner KR, Jones PL. Facioscapulohumeral muscular dystrophy family studies of DUX4 expression: evidence for disease modifiers and a quantitative model of pathogenesis. Hum Mol Genet. 2012 Oct 15;21(20):4419-30. doi: 10.1093/hmg/dds284. Epub 2012 Jul 13."
                },
                {
                    "pmid": "19359275",
                    "type": "BACKGROUND",
                    "citation": "Snider L, Asawachaicharn A, Tyler AE, Geng LN, Petek LM, Maves L, Miller DG, Lemmers RJ, Winokur ST, Tawil R, van der Maarel SM, Filippova GN, Tapscott SJ. RNA transcripts, miRNA-sized fragments and proteins produced from D4Z4 units: new candidates for the pathophysiology of facioscapulohumeral dystrophy. Hum Mol Genet. 2009 Jul 1;18(13):2414-30. doi: 10.1093/hmg/ddp180. Epub 2009 Apr 9."
                },
                {
                    "pmid": "30312408",
                    "type": "BACKGROUND",
                    "citation": "Wang LH, Friedman SD, Shaw D, Snider L, Wong CJ, Budech CB, Poliachik SL, Gove NE, Lewis LM, Campbell AE, Lemmers RJFL, Maarel SM, Tapscott SJ, Tawil RN. MRI-informed muscle biopsies correlate MRI with pathology and DUX4 target gene expression in FSHD. Hum Mol Genet. 2019 Feb 1;28(3):476-486. doi: 10.1093/hmg/ddy364."
                },
                {
                    "pmid": "24861551",
                    "type": "BACKGROUND",
                    "citation": "Yao Z, Snider L, Balog J, Lemmers RJ, Van Der Maarel SM, Tawil R, Tapscott SJ. DUX4-induced gene expression is the major molecular signature in FSHD skeletal muscle. Hum Mol Genet. 2014 Oct 15;23(20):5342-52. doi: 10.1093/hmg/ddu251. Epub 2014 May 26."
                }
            ]
        },
        "ipdSharingStatementModule": {
            "ipdSharing": "UNDECIDED",
            "description": "We will be willing to share de-identified data following the execution of a Data Use Agreement."
        }
    },
    "derivedSection": {
        "miscInfoModule": {
            "versionHolder": "2024-07-30"
        },
        "conditionBrowseModule": {
            "meshes": [
                {
                    "id": "D000020391",
                    "term": "Muscular Dystrophy, Facioscapulohumeral"
                }
            ],
            "ancestors": [
                {
                    "id": "D000009136",
                    "term": "Muscular Dystrophies"
                },
                {
                    "id": "D000020966",
                    "term": "Muscular Disorders, Atrophic"
                },
                {
                    "id": "D000009135",
                    "term": "Muscular Diseases"
                },
                {
                    "id": "D000009140",
                    "term": "Musculoskeletal Diseases"
                },
                {
                    "id": "D000009468",
                    "term": "Neuromuscular Diseases"
                },
                {
                    "id": "D000009422",
                    "term": "Nervous System Diseases"
                },
                {
                    "id": "D000030342",
                    "term": "Genetic Diseases, Inborn"
                }
            ],
            "browseLeaves": [
                {
                    "id": "M12093",
                    "name": "Muscular Dystrophies",
                    "relevance": "LOW"
                },
                {
                    "id": "M22188",
                    "name": "Muscular Dystrophy, Facioscapulohumeral",
                    "asFound": "Facio-Scapulo-Humeral Dystrophy",
                    "relevance": "HIGH"
                },
                {
                    "id": "M12092",
                    "name": "Muscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M4589",
                    "name": "Atrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "M22697",
                    "name": "Muscular Disorders, Atrophic",
                    "relevance": "LOW"
                },
                {
                    "id": "M12097",
                    "name": "Musculoskeletal Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M12411",
                    "name": "Neuromuscular Diseases",
                    "relevance": "LOW"
                },
                {
                    "id": "M23686",
                    "name": "Genetic Diseases, Inborn",
                    "relevance": "LOW"
                },
                {
                    "id": "T3963",
                    "name": "Muscular Dystrophy",
                    "relevance": "LOW"
                },
                {
                    "id": "T2182",
                    "name": "Facioscapulohumeral Muscular Dystrophy",
                    "asFound": "Facio-Scapulo-Humeral Dystrophy",
                    "relevance": "HIGH"
                }
            ],
            "browseBranches": [
                {
                    "abbrev": "BC05",
                    "name": "Musculoskeletal Diseases"
                },
                {
                    "abbrev": "BC10",
                    "name": "Nervous System Diseases"
                },
                {
                    "abbrev": "BC16",
                    "name": "Diseases and Abnormalities at or Before Birth"
                },
                {
                    "abbrev": "All",
                    "name": "All Conditions"
                },
                {
                    "abbrev": "BC23",
                    "name": "Symptoms and General Pathology"
                },
                {
                    "abbrev": "Rare",
                    "name": "Rare Diseases"
                }
            ]
        }
    },
    "hasResults": false
}